A Quick Look at Today's Ratings for Waters(WAT.US), With a Forecast Between $390 to $440
Waters (WAT) Gets a Hold From J.P. Morgan
Waters Analyst Ratings
Waters (WAT) Gets a Hold From Stifel Nicolaus
TD Cowen Remains a Hold on Waters (WAT)
Citi Maintains Waters(WAT.US) With Hold Rating, Raises Target Price to $390
BofA Securities Maintains Waters(WAT.US) With Hold Rating, Maintains Target Price $410
Balanced Outlook: Waters Corporation's Growth Prospects and Risks Underpin Hold Rating
JPMorgan Adjusts Price Target on Waters to $390 From $380, Maintains Neutral Rating
Barclays Maintains Waters(WAT.US) With Hold Rating, Maintains Target Price $400
Jefferies Maintains Waters(WAT.US) With Buy Rating, Maintains Target Price $435
Waters Corporation: Strategic Positioning and Growth Prospects Justify Buy Rating
Analysts Offer Insights on Healthcare Companies: Waters (WAT), Alkermes (ALKS) and Replimune Group (REPL)
Jefferies Maintains Waters(WAT.US) With Buy Rating, Raises Target Price to $435
Scotiabank Upgrades Waters to Sector Outperform, $450 Price Target
Waters (WAT) Receives a Hold From Stifel Nicolaus
A Quick Look at Today's Ratings for Waters(WAT.US), With a Forecast Between $400 to $450
Waters Corp Is Maintained at Neutral by B of A Securities
Waters Analyst Ratings
Evercore ISI Adjusts Waters Price Target to $395 From $390